


Pharmaceuticals & Biotechnology | Small Cap
Wanbury Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by high return on capital employed and return on assets. Growth is supported by significant increases in operating profit and assets. However, the company faces challenges in liquidity, efficiency, and certain financial metrics, particularly related to earnings per share and revenue growth. Coverage ratios are moderate, indicating an ability to meet interest obligations but a lack of dividend coverage. Overall, Wanbury Ltd exhibits potential for sustained profitability and asset expansion, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Wanbury Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by high return on capital employed and return on assets. Growth is supported by significant increases in operating profit and assets. However, the company faces challenges in liquidity, efficiency, and certain financial metrics, particularly related to earnings per share and revenue growth. Coverage ratios are moderate, indicating an ability to meet interest obligations but a lack of dividend coverage. Overall, Wanbury Ltd exhibits potential for sustained profitability and asset expansion, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
14.49
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
29.43
P/B RATIO
15.15
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
1.51
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
13.23
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹274.25 as on Aug 6, 2026.
The growth metrics indicate a mixed performance. While the company shows significant growth in operating profit and assets, revenue and net income growth rates are low. There is a need to improve revenue generation to ensure balanced and sustainable growth across all key areas.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 6.81 | 30.36 | -5.09 | 19.18 | 3.81 |
| Operating Profit Growth Rate | -21.74 | 100 | -27.78 | 188.46 | 6.67 |
| Earnings Per Share (EPS) Growth | -119.54 | -594.84 | -112.75 | -637.42 | -45.47 |
| Asset Growth Rate | 3.58 | 22.15 | -13.88 | 12.83 | 20.7 |
| Net Income Growth Rate | -120.31 | -723.08 | -112.35 | -660 | -44.64 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 2 | Lincoln Pharmaceuticals Ltd | 7.31 | 13.81 | Neutral | 98.00 | 43.88 | 88.00 |
| 3 | Kilitch Drugs (India) Ltd | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 4 | NGL Fine Chem Ltd | 6.98 | 44.01 | Overvalued | 73.00 | 67.39 | 48.00 |
| 5 | Sakar Healthcare Ltd | 6.89 | 67.13 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 6 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 7 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 8 | SMS Lifesciences India Ltd | 6.59 | 21.63 | Undervalued | 45.00 | 58.80 | 19.00 |
| 9 | Hester Biosciences Ltd | 6.54 | 37.59 | Neutral | 87.00 | 61.24 | 57.00 |
| 10 | Infinium Pharmachem Ltd | 6.42 | 26.92 | Neutral | 22.00 | 6.43 | 14.00 |
| 11 | Medicamen Biotech Ltd | 5.73 | 33.43 | Neutral | 20.00 | 6.94 | 10.00 |
| 12 | Albert David Ltd | 5.63 | -279.90 | Neutral | 5.00 | -2.62 | -1.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.82 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 47.48 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 29.43 | Neutral | 88.00 | 18.93 | 43.00 |
| 17 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral